Braidwell LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Braidwell LP disclosed 73 US equity positions worth $3.4bn in its Q4 2024 13F filing. The largest position was GH at 6.7% of the reported book, followed by BBIO and NVCR. Against the Q3 2024 filing, it opened 5 new positions, added to 21 and reduced 13 among the top 50 holdings.
What did Braidwell LP own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | GH GUARDANT HEALTH INC | 6.7% | $226.0m | 268,252,000 | 0% | held | |
| 2 | BBIO BRIDGEBIO PHARMA INC | 4.4% | $148.1m | 140,838,000 | 0% | held | |
| 3 | NVCR NOVOCURE LTD | 4.0% | $134.5m | 140,834,000 | 0% | held | |
| 4 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 3.6% | $123.1m | 901,790 | -2% | reduced |
| 5 | RGEN REPLIGEN CORP | 3.4% | $114.8m | 112,000,000 | – | new | |
| 6 | XENE XENON PHARMACEUTICALS INC | Healthcare | 3.4% | $114.2m | 2,913,964 | 8% | added |
| 7 | NUVASIVE INC | 3.4% | $113.2m | 114,206,000 | 0% | held | |
| 8 | NEOGENOMICS INC | 2.9% | $98.3m | 116,381,000 | 0% | held | |
| 9 | LEGN LEGEND BIOTECH CORP | Healthcare | 2.9% | $96.9m | 2,977,951 | 93% | added |
| 10 | CGON CG ONCOLOGY INC | Healthcare | 2.8% | $94.2m | 3,283,317 | 4% | added |
| 11 | GH GUARDANT HEALTH INC | Healthcare | 2.6% | $87.0m | 2,847,931 | -15% | reduced |
| 12 | IRONWOOD PHARMACEUTICALS INC | 2.5% | $85.2m | 92,740,000 | 0% | held | |
| 13 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 2.3% | $78.2m | 375,179 | 20% | added |
| 14 | DEXCOM INC | 2.2% | $74.4m | 82,700,000 | -11% | reduced | |
| 15 | APGE APOGEE THERAPEUTICS INC | Healthcare | 2.1% | $69.8m | 1,540,362 | -6% | reduced |
| 16 | KINIKSA PHARMACEUTICALS INTL | 2.0% | $68.3m | 3,452,447 | 19% | added | |
| 17 | APLSUSD APELLIS PHARMACEUTICALS INC | 2.0% | $67.0m | 2,098,866 | -33% | reduced | |
| 18 | IRTC IRHYTHM TECHNOLOGIES INC | Healthcare | 1.9% | $63.6m | 705,391 | -10% | reduced |
| 19 | EWTX EDGEWISE THERAPEUTICS INC | 1.8% | $62.3m | 2,332,196 | 19% | added | |
| 20 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 1.8% | $61.8m | 4,873,853 | 0% | held | |
| 21 | SYRE SPYRE THERAPEUTICS INC | 1.8% | $60.0m | 2,578,404 | 18% | added | |
| 22 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.8% | $59.5m | 1,479,666 | 28% | added |
| 23 | TMDX TRANSMEDICS GROUP INC | Healthcare | 1.7% | $57.5m | 922,100 | – | new |
| 24 | ALPHATEC HLDGS INC | 1.6% | $55.1m | 58,217,000 | 0% | held | |
| 25 | INSP INSPIRE MED SYS INC | Healthcare | 1.6% | $54.4m | 293,410 | 23% | added |
| 26 | ARGX ARGENX SE | Healthcare | 1.5% | $49.7m | 80,766 | -16% | reduced |
| 27 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 1.4% | $46.7m | 89,754 | – | new |
| 28 | BBIO BRIDGEBIO PHARMA INC | 1.4% | $46.0m | 53,594,000 | 0% | held | |
| 29 | MRVI MARAVAI LIFESCIENCES HLDGS I | Healthcare | 1.3% | $45.5m | 8,353,287 | 0% | held |
| 30 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 1.3% | $44.4m | 364,900 | -1% | reduced |
| 31 | PEN PENUMBRA INC | Healthcare | 1.3% | $43.7m | 183,828 | -49% | reduced |
| 32 | GKOS GLAUKOS CORP | Healthcare | 1.3% | $43.3m | 288,876 | -7% | reduced |
| 33 | AVADEL PHARMACEUTICALS PLC | 1.3% | $43.2m | 4,105,726 | 21% | added | |
| 34 | RGEN REPLIGEN CORP | Healthcare | 1.2% | $40.9m | 283,823 | -28% | reduced |
| 35 | FNAUSD PARAGON 28 INC | 1.2% | $39.6m | 3,834,809 | -7% | reduced | |
| 36 | ISRG INTUITIVE SURGICAL INC | Healthcare | 1.2% | $39.3m | 75,300 | -18% | reduced |
| 37 | ATEC ALPHATEC HLDGS INC | Healthcare | 1.2% | $39.1m | 4,256,490 | 5% | added |
| 38 | BNTX BIONTECH SE | Healthcare | 1.0% | $35.3m | 309,865 | 25% | added |
| 39 | BCAX BICARA THERAPEUTICS INC | 1.0% | $34.9m | 2,000,659 | 21% | added | |
| 40 | KRYS KRYSTAL BIOTECH INC | Healthcare | 0.9% | $31.4m | 200,500 | 19% | added |
| 41 | HROW HARROW INC | 0.9% | $30.4m | 907,039 | 106% | added | |
| 42 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.9% | $30.0m | 1,894,439 | 168% | added |
| 43 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.8% | $27.1m | 1,147,676 | 123% | added |
| 44 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 0.8% | $26.3m | 1,206,589 | 144% | added |
| 45 | KIDS ORTHOPEDIATRICS CORP | Healthcare | 0.8% | $25.7m | 1,107,770 | 0% | held |
| 46 | IMTX IMMATICS N.V | Healthcare | 0.7% | $24.9m | 3,503,965 | 113% | added |
| 47 | GERN GERON CORP | Healthcare | 0.7% | $24.8m | 7,006,315 | – | new |
| 48 | IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 0.7% | $24.1m | 5,440,277 | 23% | added |
| 49 | BRKR BRUKER CORP | Healthcare | 0.6% | $20.7m | 353,200 | – | new |
| 50 | EXK EXACT SCIENCES CORP | Basic Materials | 0.6% | $19.8m | 353,000 | 23% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.